AMT, INC.

Basic Information

508 HEARTWOOD RD
CHERRY HILL, NJ 08003
CHERRY HILL, NJ, 08003

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. ENDOSCOPIC LIGHT SOURCE FOR PDT

    Amount: $278,132.00

    DESCRIPTION (Verbatim from the Applicant's Abstract): We propose to continue to develop and test a self-contained light delivery device for use in photodynamic therapy (PDT) for Barrett's es ...

    STTR Phase II 2001 Department of Health and Human Services
  2. ENDOSCOPIC LIGHT SOURCE FOR PDT

    Amount: $0.00

    DESCRIPTION (Verbatim from the Applicant's Abstract): We propose to continue to develop and test a self-contained light delivery device for use in photodynamic therapy (PDT) for Barrett's es ...

    STTR Phase I 2001 Department of Health and Human Services
  3. N/A

    Amount: $100,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  4. THERMODILUTION RIGHT VENTRICULAR EJECTION FRACTION

    Amount: $100,000.00

    N/A

    STTR Phase I 1999 Department of Health and Human Services
  5. MICROWAVE AIDED LIPOSUCTION

    Amount: $100,000.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  6. POLYMERIC DELIVERY SYSTEMS FOR ANTIRETROVIRAL AGENTS

    Amount: $49,855.00

    THE GOAL OF THIS PHASE I RESEARCH IS TO DESIGN, SYNTHESIZE, DEVELOP, AND EVALUATE THE IN VITRO EFFICACY OF A NEW CLASS OF POLYMERIC "TARGETED" PRODRUGS OF AZT. THE OVERALL OBJECTIVE OF THIS PROGRAM IS ...

    SBIR Phase I 1990 Department of Health and Human Services
  7. SOLUBILIZATION AND SUSTAINED DELIVERY OF ANTITUMOR AGENTS

    Amount: $49,838.00

    THE OVERALL OBJECTIVE IS TO PROVIDE A NEW DRUG DELIVERY SYSTEM AND TO ENHANCE THE SOLUBILITY OF EXISTING COMPOUNDS THAT EXHIBIT EXCELLENT ANTITUMOR PROPERTIES BUT ARE INSOLUBLE IN WATER. AQUEOUS SOLUB ...

    SBIR Phase I 1990 Department of Health and Human Services
  8. NEW TARGET-DIRECTED PT-PORPHYRIN ANTICANCER DRUGS

    Amount: $46,000.00

    THE OBJECTIVE OF THIS PROJECT IS TO IMPROVE THE SELECTIVITY OF ACTION OF PLATINUM ANTITUMOR AGENTS. PLATINUM COMPOUNDS HAVE SHOWN ACTIVITY IN MANY TYPES OF TUMORS, BUT SEVERE DOSE-LIMITING SIDE EFFECT ...

    SBIR Phase I 1987 Department of Health and Human Services
  9. MECHANISM-BASED ELASTASE INHIBITORS

    Amount: $50,000.00

    SYNTHETIC ELASTASE INHIBITORS FOR USE IN THE TREATMENT OF EMPHYSEMA WILL BE DEVELOPED. IN PHASE I, NEW MECHANISM-BASED ELASTASE INHIBITORS WILL BE SYNTHESIZED, CHARACTERIZED, AND STUDIED AS INHIBITORS ...

    SBIR Phase I 1987 Department of Health and Human Services
  10. THE COMPLEX 4-CARBOXYPHTHALATO (1, 2-DIAMINOCYCLOHEXANE) PLATINUM (NSC 271674; DACH-PT) HAS UNDERGONE LIMITED CLINICAL TRIALS.

    Amount: $50,000.00

    THE COMPLEX 4-CARBOXYPHTHALATO (1, 2-DIAMINOCYCLOHEXANE) PLATINUM (NSC 271674; DACH-PT) HAS UNDERGONE LIMITED CLINICAL TRIALS. DESIGNED AS AN ALTERNATIVE THERAPY TO CISPLATIN, IT HAS DEMONSTRATED SUBS ...

    SBIR Phase I 1986 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government